NORTH AMERICA WOUND DEBRIDEMENT PRODUCTS MARKET ANALYSIS

North America Wound Debridement Products MarketSize and Trends

The North America Wound Debridement Products Market is estimated to be valued at US$ 297.1 million in 2023 and is expected to exhibit a CAGR of 7.6 % during the forecast period (2023-2030).

Based on Product type, the North America Wound debridement products market is segmented into hydrosurgical debridement devices, low frequency ultrasound devices, surgical wound debridement devices, mechanical debridement pads, traditional wound debridement devices, larval therapy. Out of which, low frequency ultrasound devices are expected to dominate the North America wound debridement products market during the forecast period, and this is due to the increasing demand of ultrasonic devices of wound debridement management.

Based on Applications, the North America wound debridement products market is segmented into chronic ulcers, surgical wounds, traumatic wounds, burn cases. The chronic ulcers segment is expected to dominate the market over the forecast period and this is attributed to the increasing number of geriatric population in North America region.

Based on End user, the North America wound debridement products market is segmented into hospital, ambulatory surgical centers, specialized clinics, nursing facilities, others. The hospitals are expected to dominate the market over the forecast period and this is due to the increasing numbers of hospitals in North America region.

Among all segmentation, the product type segment has the highest potential due to the increasing approvals of wound debridement products by the key market players. For instance, on August 28, 2020, Tissue Regeneration technologies, LLC, a U.S.-based medical device company, received U.S. Food and drug administration approval for its product SoftWave, a tissue regeneration technology for treatment of burn wound.

North America Wound Debridement Products Market: Key Trends

Awareness programs by key market players

On June 4, 2021, Sanara MedTech Inc., a U.S.-based surgical and chronic wound care product provider announced partnership with Pixalere Healthcare Inc., a Canada-based wound care Software Company, to advance its comprehensive wound and skin care strategy. The goal behind this partnership is to use Pixalere’s technology, including decision support, documentation, and wound tracking analytics, with complementary Sanara solutions that offer virtual access to expert wound and skin physicians, advanced diagnostics, and wound care product order fulfillment.